(Q53305736)

13 May 2018

title

Long-term survival of patients with sarcomatoid renal cell cancer treated with chemotherapy. (English)

1 reference

13 May 2018

sarcomatoid renal cell carcinoma

1 reference

1 reference

1

Janice P Dutcher

1 reference

13 May 2018

author name string

David Nanus

series ordinal

2

1 reference

13 May 2018

publication date

18 August 2010

1 reference

13 May 2018

published in

Medical Oncology

1 reference

13 May 2018

volume

28

1 reference

13 May 2018

issue

4

1 reference

13 May 2018

page(s)

1530-1533

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s12032-010-9649-2

exact match

0 references

cites work

Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Sustained response of sarcomatoid renal-cell carcinoma to MAID chemotherapy: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Sarcomatoid renal cell carcinoma. A treatable entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9649-2

Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases

21 January 2018

1 reference

12 December 2020

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer

1 reference

12 December 2020

Gemcitabine: a phase II study in patients with advanced renal cancer

1 reference

12 December 2020

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria

1 reference

12 December 2020

Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors.

1 reference

12 December 2020

Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma

1 reference

12 December 2020

A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802

1 reference

12 December 2020

Immunohistochemical Expression of Hypoxia Inducible Factor-1α and its Downstream Molecules in Sarcomatoid Renal Cell Carcinoma

1 reference

12 December 2020

Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers

1 reference

12 December 2020

Gemcitabine in advanced renal cell carcinoma. A phase II study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

12 December 2020

Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique

1 reference

12 December 2020

Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience

1 reference

12 December 2020

Gemcitabine plus Epi-doxorubicin as first-line chemotherapy for bladder cancer in advanced or metastatic stage: a phase II.

1 reference

12 December 2020

Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome

1 reference

12 December 2020

10.1007/S12032-010-9649-2

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018